|
|
Article: FDA approves Takeda's ACTOplus met.(Takeda Pharmaceuticals, Rozerem)(Brief Article)
- Article from:
- Pharma Marketletter
- Article date:
- September 5, 2005
CopyrightCOPYRIGHT 2005 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The North American division of Japanese drugmaker Takeda Pharmaceuticals says that the US Food and Drug Administration has approved its New Drug Application for ACTOplus met (pioglitazone HCl and metformin HCl) for the treatment of type 2 diabetes, making it the second Takeda product approved in this important US market this summer, ...
Related newspaper, magazine, and journal articles:
|